Introduction

When the British National Institute for Health and Care Excellence (NICE) approved ultrasound-guided foam treatment of varicose veins in 2005, Jes Sanddal Lindholt went to the Vein Institute in London to learn and implemented the treatment as the first in Denmark at Viborg Hospital and shortly after at Viborg Private Hospital. Later at the Vein Clinic in Nyborg. Over the years, Jes has treated more than 1000 patients and gained extensive experience with the treatment.
When the Danish National Board of Health changed the recommendations for varicose vein treatment in 2009 to the effect that surgical treatment should only be performed when other endovascular options have been exhausted, Jes developed a two-phase treatment that largely made surgical treatment unnecessary.

Additional areas of expertise have been gained through Jes' primary research area: Aortic aneurysm and prevention of cardiovascular disease. Through large preventive population studies, most recently VIVA and DANCAVAS, he has gained great insight into these obstructions and atherosclerosis in the legs and is internationally recognized.

Jes received the Odd Fellow Researcher Award in 2016 after a joint nomination from the University of Copenhagen, Aarhus University and the University of Southern Denmark.

Main research areas
Cardiovascular epidemiology and prevention, public health and translational medicine

Education and training

• 2010: Medical degree in science (Dr.med), Aarhus University.
• 2006: FEBVS - Fellow of the European Board of Vascular Surgery.
• 2003: Specialist in vascular surgery, Danish Health Authority.
• 1998: PhD in Medicine, Aarhus University.
• 1990: Degree of Master of Medicine (MD), Aarhus University.

Experience

• 2018-: Consultant in vascular surgery, Capio Odense.
• 2012-: Professor of Vascular Surgery, Head of the Cardiovascular Excellence Center in Region South (CAVAC), Head of Research, Department of Cardiac, Pulmonary and Vascular Surgery T, Odense University Hospital, Syddank University.
• Adjunct Professor in Vascular Epidemiology, Aarhus University.
• 2011-2012: Professor of Vascular Epidemiology, Aarhus University.
• 20042011: Assoc. professor and consultant in vascular surgery, Viborg Hospital.
• 2005-2012: Consultant in vascular surgery, Viborg Privathospital.
• 2000-2004: Specialist training in vascular surgery, Viborg Hospital and Rigshospitalet.
• 1997-2000: Resident physician, Viborg Hospital and University Hospital Skejby.
• 1994-1996: Candidate fellow, Department of Epidemiology, Aarhus University.
• 1990-1994: Resident physician.

Other information

Scientific and administrative management

• Head of Research at Department of Cardiothoracic, Pulmonary and Vascular Surgery T, Odense University Hospital
• Head of the Clinical Cardiovascular Excellence Center r Region Syd (CAVAC)
• Director of the Elite Research Center for Individualized Medicine of Arterial Disease (CIMA)
• Member of the Research Council at Odense University Hospital
• Member of the Danish Heart Foundation's research committee
• Member of the advisory board for the Danish Health Authority on national screening programs
• Trial manager for VIVA - a screening trial of +50,000 men
• Study manager for DANCAVAS - a screening study of +45,000 men

International collaborations

• CASS: Collaboration on Aneurysm Screening Studies (UK, AUS, DK)
• FAD: Fighting Aneurysmal Disease (FAD) - EU-FP7 grant no. 200647 - (15 centers)
• AAA-CONSORTIUM: Global consortium pooling DNA samples for GWAS (32 centers)
• RESCAN: Global consortium merging cohort data from AAA (16 centers)
• The Transatlantic Innovative Research Consortium: Atherosclerosis, Aneurysm and Autoimmunity
• The International AAA Screening Group
• Transatlantic Research Consortium: Adventitial Causes of Aneurysms (6 centers)